Related content

Urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitor type 1 (PAI-1) in tissue and serum of head and neck squamous cell carcinoma patients

By Strojan P.   Budihna M.   S   mid L.   Vrhovec I.   S   krk J.  

European Journal of Cancer, Vol. 34, Iss. 8, 1998-07 ,pp. : 1193-1197

Elsevier

Access to resources Recommend Favorite

Simultaneous up-regulation of urokinase-type plasminogen activator (uPA) and uPA receptor by hepatocyte growth factor/scatter factor in human glioma cells

By Moriyama Takuzou   Kataoka Hiroaki   Hamasuna Ryouichi   Yoshida Etsuo   Sameshima Tetsuro   Iseda Tsutomu   Yokogami Kiyotaka   Nakano Shinichi   Koono Masashi   Wakisaka Shinichiro  

Clinical and Experimental Metastasis, Vol. 17, Iss. 10, 1999-12 ,pp. : 873-879

Springer Publishing Company

Access to resources Recommend Favorite

Immunoassays (ELISA) of Urokinase-type Plasminogen Activator (uPA): Report of an EORTC/BIOMED-1 Workshop

By Benraad T.J.   Geurts-Moespot J.   Grondahl-Hansen J.   Schmitt M.   Heuvel J.J.T.M.   de Witte J.H.   Foekens J.A.   Leake R.E.   Brunner N.   Sweep C.G.J.  

European Journal of Cancer, Vol. 32, Iss. 8, 1996-07 ,pp. : 1371-1381

Elsevier

Access to resources Recommend Favorite

Celecoxib Inhibits Urokinase-Type Plasminogen Activator (uPA) Production in MDA-MB-231 Breast Cancer Cells

By Andrews Heather   Habibi Golerah   Kucab Jill   Dunn Sandra  

Breast Cancer Research and Treatment, Vol. 94, Iss. 1, 2005-11 ,pp. : 47-52

Springer Publishing Company

Access to resources Recommend Favorite

Downregulation of urokinase-type plasminogen activator receptor (uPAR) induces caspase-mediated cell death in human glioblastoma cells

By Yanamandra Niranjan   Konduri Santhi   Mohanam Sanjeeva   Dinh Dzung   Olivero William   Gujrati Meena   Nicolson Garth   Obeyeseke Mandri   Rao Jasti  

Clinical and Experimental Metastasis, Vol. 18, Iss. 7, 2000-11 ,pp. : 611-615

Springer Publishing Company

Access to resources Recommend Favorite